AI-generated summary
The authors studied 11 men with type 2 diabetes who received light-emitting diode photobiomodulation (150 J, 300 J or placebo) before a constant-load cycling test, measuring baroreflex sensitivity at rest, during exercise and in recovery. They report that baroreflex sensitivity changed with condition but not differently by therapy, so photobiomodulation did not improve it. The small sample size is a key limitation.
- Participants
- 11
- Who or what was studied
- Men with type 2 diabetes aged 40 to 64 years
- Limits stated in the abstract
- Very small sample of 11 men with no stated control group details beyond placebo, and the abstract does not report wavelengths.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Total energy
- 150 J, 300 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.